Lantheus Holdings (LNTH) Operating Margin Growth (5y) (2019 - 2026)
Lantheus Holdings (LNTH) Operating Margin Growth (5y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.36 Bn | 43.40 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.72 Bn | 40.07 Bn | 2.15 Bn |
| 3 | Zoetis | 32.51 Bn | 30.84 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.13 Bn | 19.47 Bn | 683.80 Mn |
| 6 | Viatris | 18.91 Bn | 18.02 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.47 Bn | 15.08 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.15 Bn | 9.99 Bn | - |
| 10 | Lantheus Holdings | 6.53 Bn | 5.93 Bn | 241.86 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 5,232.00 |
| Mar 31, 2026 | 467.00 |
| Dec 31, 2025 | 1,953.00 |
| Sep 30, 2025 | 1,729.00 |
| Jun 30, 2025 | 3,167.00 |
| Mar 31, 2025 | 1,953.00 |
| Dec 31, 2024 | 1,519.00 |
| Sep 30, 2024 | 2,538.00 |
| Jun 30, 2024 | 911.00 |
| Mar 31, 2024 | 1,013.00 |
| Dec 31, 2023 | 89,693.00 |
| Sep 30, 2023 | 1,658.00 |
| Jun 30, 2023 | 1,998.00 |
| Mar 31, 2023 | -2,143.00 |
| Dec 31, 2022 | -7,657.00 |
| Sep 30, 2022 | 1,979.00 |
| Jun 30, 2022 | 811.00 |
| Mar 31, 2022 | 1,355.00 |
| Dec 31, 2021 | -4,360.00 |
| Sep 30, 2021 | -3,128.00 |